Tuesday, March 28, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biosecurity

DoD Seeks Countermeasures Against Filoviridae Viruses

by Global Biodefense Staff
February 23, 2015

The Department of Defense is seeking to develop antiviral therapeutic medical countermeasures effective against naturally occurring or biologically engineered Filoviridae viruses.

The effort is managed by the Emerging Infectious Diseases Therapeutics (EID Tx) program under the Joint Product Manager Biological Defense Therapeutics (JPdM-BDTX).

EID Tx is specifically interested in an antiviral therapeutic that addresses one or more Filoviridae (Ebola Zaire, Ebola Sudan, Marburg) with the potential of addressing additional Biological Warfare Agents beyond the Filoviridae indication targeting the following virus families:

  • Arenaviridae – Lassa Fever, Junin
  • Bunyaviridae – Hantaan
  • Filoviridae – Tai Forest, Bundibugyo
  • Togaviridae – Eastern Equine Encephalitis, Western Equine Encephalitis, Venezuelan Equine Encephalitis

The program is soliciting capability statements under a new Request for Information (RFI). A similar RFI was posted April 2, 2014 under Announcement Number HDTRA1-14-JPM-0001 and previous responders are requested by the DoD to send confirmation of continued interest.

Further details are available via Solicitation Number: W911QY-15-S-BDTX. The response deadline is Feb. 26, 2015.

Tags: AntiviralsEbolaEquine EncephalitisLassa Fever

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions
Pathogens

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
small glass vials on an assembly line await filling of vaccine solution
Industry News

Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding

January 12, 2023
Load More

Latest News

Biodefense Headlines – 26 March 2023

March 26, 2023
Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC